Share
Sagicor Life Jamaica Limited has announced updates to a number of its critical illness plans.
Effective October 1, 2025, clients with eligible critical illness plans can now benefit from coverage for early-stage cancer, which offers faster financial support. The new feature provides a partial payout on diagnosis of early-stage breast or prostate cancer.
Clients insured under these critical illness plans, diagnosed on or after October 1, 2025, with non-invasive breast cancer (Ductal Carcinoma In Situ), can claim a 25% advance payout of their sum insured (up to J$1.25 million), on their first diagnosis of the early-stage cancer.
The update to Sagicor’s critical illness plans also covers early-stage prostate cancers (T1A N0 M0 and T1B N0 M0 or equivalent stages).
This early payout for these conditions is a first for insurance companies in Jamaica. Note that only the first diagnosis is covered for each client, per eligible policy.
CEO of Sagicor Life, Willard Brown says, “As our clients’ needs evolve, we are committed to evolving with them.”
He adds that the new benefit, “Represents Sagicor’s pledge to offer meaningful protection at the earliest signs of breast and prostate cancer, giving clients support and peace of mind, while emphasising early screening.”
